Article info
PDFOriginal research
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
- Correspondence to Dr William Tew, Gynecologic Medical Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; teww{at}mskcc.org
Citation
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
Publication history
- Received October 11, 2019
- Revision received December 10, 2019
- Accepted December 17, 2019
- First published June 9, 2020.
Online issue publication
January 08, 2022
Article Versions
- Previous version (6 October 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.